Verve Therapeutics (NASDAQ:VERV) shares climbed ~23% in the premarket on Monday after the company said its gene editing ...

Stem cell therapies are a safe and effective way of treating Parkinson's disease, according to results of two independent ...

In this parallel design, randomized trial, intensive treatment of systolic blood pressure (SBP) resulted in a lower incidence ...

KYOTO—Researchers have safely transplanted nerve cells generated from induced pluripotent stem (iPS) cells into the brains of ...

Eyestem Research Pvt Ltd announced positive results from its phase 1/2 trial ( NCT06394232) evaluating its investigational ...

Hoth Therapeutics, Inc.(NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative therapies for patients with high unmet medical needs, today announced positive interim data from the ...

Arvinas (ARVN) presented data from the first-in-human clinical trial of ARV-102, the Company’s investigational PROteolysis TArgeting Chimera ...

CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to ...